BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10784423)

  • 21. The binding of lactoferrin to glycosaminoglycans on enterocyte-like HT29-18-C1 cells is mediated through basic residues located in the N-terminus.
    El Yazidi-Belkoura I; Legrand D; Nuijens J; Slomianny MC; van Berkel P; Spik G
    Biochim Biophys Acta; 2001 Dec; 1568(3):197-204. PubMed ID: 11786226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant human intelectin binds bovine lactoferrin and its peptides.
    Shin K; Wakabayashi H; Yamauchi K; Yaeshima T; Iwatsuki K
    Biol Pharm Bull; 2008 Aug; 31(8):1605-8. PubMed ID: 18670097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lactoferrin-binding proteins in Shigella flexneri.
    Tigyi Z; Kishore AR; Maeland JA; Forsgren A; Naidu AS
    Infect Immun; 1992 Jul; 60(7):2619-26. PubMed ID: 1319403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ability of lactoferrin to promote the growth of Bifidobacterium spp. in vitro is independent of receptor binding capacity and iron saturation level.
    Petschow BW; Talbott RD; Batema RP
    J Med Microbiol; 1999 Jun; 48(6):541-549. PubMed ID: 10359303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the interaction of glycyrrhizin and glycyrrhetinic acid with bovine serum albumin by spectrophotometric-gradient flow injection titration technique and molecular modeling simulations.
    Manouchehri F; Izadmanesh Y; Ghasemi JB
    Int J Biol Macromol; 2017 Sep; 102():92-103. PubMed ID: 28377238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Featured Prebiotic Agent: The Roles and Mechanisms of Direct and Indirect Prebiotic Activities of Lactoferrin and Its Application in Disease Control.
    Liu ZS; Chen PW
    Nutrients; 2023 Jun; 15(12):. PubMed ID: 37375663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific binding of lactoferrin to Escherichia coli isolated from human intestinal infections.
    Naidu SS; Erdei J; Czirók E; Kalfas S; Gadó I; Thorén A; Forsgren A; Naidu AS
    APMIS; 1991 Dec; 99(12):1142-50. PubMed ID: 1772651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physiological correlation between glycyrrhizin, glycyrrhizin-binding lipoxygenase and casein kinase II.
    Shimoyama Y; Ohtaka H; Nagata N; Munakata H; Hayashi N; Ohtsuki K
    FEBS Lett; 1996 Aug; 391(3):238-42. PubMed ID: 8764981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of glycyrrhizin and glycyrrhetinic acid with DNA.
    Nafisi S; Bonsaii M; Manouchehri F; Abdi K
    DNA Cell Biol; 2012 Jan; 31(1):114-21. PubMed ID: 22074129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of secretory type IIA phospholipase A2 (sPLA2-IIA) as a glycyrrhizin (GL)-binding protein and the GL-induced inhibition of the CK-II-mediated stimulation of sPLA2-IIA activity in vitro.
    Shimoyama Y; Sakamoto R; Akaboshi T; Tanaka M; Ohtsuki K
    Biol Pharm Bull; 2001 Sep; 24(9):1004-8. PubMed ID: 11558558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bovine lactoferrin and Lactoferricin inhibit tumor metastasis in mice.
    Yoo YC; Watanabe S; Watanabe R; Hata K; Shimazaki K; Azuma I
    Adv Exp Med Biol; 1998; 443():285-91. PubMed ID: 9781371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells.
    Legrand D; van Berkel PH; Salmon V; van Veen HA; Slomianny MC; Nuijens JH; Spik G
    Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):841-6. PubMed ID: 9581564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bovine lactoferrin and lactoferricin exert antitumor activities on human colorectal cancer cells (HT-29) by activating various signaling pathways.
    Jiang R; Lönnerdal B
    Biochem Cell Biol; 2017 Feb; 95(1):99-109. PubMed ID: 28169560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lactoferrin and lactoferricin endocytosis halt Giardia cell growth and prevent infective cyst production.
    Frontera LS; Moyano S; Quassollo G; Lanfredi-Rangel A; Rópolo AS; Touz MC
    Sci Rep; 2018 Dec; 8(1):18020. PubMed ID: 30575774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of theaflavins on the structure and function of bovine lactoferrin.
    Wang M; Xu J; Han T; Tang L
    Food Chem; 2021 Feb; 338():128048. PubMed ID: 32950869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The detection of bovine lactoferrin binding protein on Toxoplasma gondii.
    Tanaka T; Abe Y; Kim WS; Xuan X; Nagasawa H; Igarashi I; Kumura H; Shimazaki K
    J Vet Med Sci; 2003 Dec; 65(12):1377-80. PubMed ID: 14709832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of recombinant human lactoferrin N-glycans expressed in the milk of transgenic cows.
    Parc AL; Karav S; Rouquié C; Maga EA; Bunyatratchata A; Barile D
    PLoS One; 2017; 12(2):e0171477. PubMed ID: 28170415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic and mucosal levels of lactoferrin in very low birth weight infants supplemented with bovine lactoferrin.
    Itell HL; Berenz A; Mangan RJ; Permar SR; Kaufman DA
    Biochem Cell Biol; 2021 Feb; 99(1):25-34. PubMed ID: 32841570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptides from the N-terminal end of bovine lactoferrin induce apoptosis in human leukemic (HL-60) cells.
    Roy MK; Kuwabara Y; Hara K; Watanabe Y; Tamai Y
    J Dairy Sci; 2002 Sep; 85(9):2065-74. PubMed ID: 12362437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of poly(ethylene glycol) conjugated lactoferrin for oral administration.
    Nojima Y; Suzuki Y; Iguchi K; Shiga T; Iwata A; Fujimoto T; Yoshida K; Shimizu H; Takeuchi T; Sato A
    Bioconjug Chem; 2008 Nov; 19(11):2253-9. PubMed ID: 18834167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.